Delivery Order SPE2DB20D3303-SPE2DB24FA0YP

Award Date 7/12/24
Potential Completion Date 8/2/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order valued at $7,322.67 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The order is for the supply of 420 mg Imbruvica tablets, a prescription medication, with a completion date of July 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division for the provision of IMBRUVICA 420 MG TABLET 28S, a prescription medication. The contract has a ceiling value of $7,322.67 and an ultimate completion date of May 7, 2024. This is not a set-aside contract. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the federal government, holds a larger Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of IMBRUVICA 420 MG TABLET 28S. This $7,322.67 award has a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors noted. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds an indefinite delivery...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of IMBRUVICA 420 mg tablets to support military and government healthcare programs. The $7,575.75 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a $7,845.72 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for 140 mg Imbruvica capsules. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities in support of military treatment programs and facilities worldwide....
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide IMBRUVICA 420 MG TABLET 28S. The $7,322.67 delivery order has a completion date of February 26, 2024. AmerisourceBergen Drug Corp, as the prime contractor, is a for-profit organization that holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a $7,322.67 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide IMBRUVICA 420 MG TABLET 28S. This order is a part of Amerisourcebergen's larger indefinite delivery contract (IDC) with DLA to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The IDC, which does not have a set-aside designation,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide IMBRUVICA 280 MG TABLET 28S. The contract has a potential value of $7,322.67 and a completion date of March 4, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of up to $999,999,999.00 and a performance period...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract worth $7,322.67 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of IMBRUVICA 420 MG TABLET 28S. This contract has a completion date of March 14, 2024 and was awarded on February 22, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and has previously received numerous federal contract awards from the Defense...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Imbruvica 420 mg tablets, a specialty medication, to the government. The contract has a ceiling value of $14,645.34 and runs through August 2, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA0YP
    Delivery Order

The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor, for the provision of Imbruvica 420 mg tablets. The $14,645.34 firm-fixed-price contract, which has an ultimate completion date of August 2, 2024, was awarded on July 12, 2024 without any set-aside designation.

Amerisourcebergen, a subsidiary of the Amerisourcebergen Corporation, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 10/11/24, 9:24 AM